October 21, 2025/
WATCH: National Guard case before SCOTUS; Trump insists China soybean deal coming
(The Center Square) – In today’s edition of Illinois in Focus Daily, The Center Square Editor Greg Bishop reviews the latest in the legal battle over whether the Trump administration can use the National Guard for public safety in Illinois with an emergency motion to the U.S. Supreme Court.
Bishop also shares the latest comments from President Donald Trump about the status of soybean sales to China, which didn’t buy any soybeans in the most recent report from the USDA. Illinois is the largest producer of soybeans in the country.
Subscribe to Illinois in Focus Daily with The Center Square on YouTube. You can also subscribe to the Illinois in Focus podcast to get the entire show uninterrupted.
Events
Latest News Stories
Illinois’ ‘F’ grade leaves taxpayers on the hook for billions, watchdog says
By Catrina Barker | The Center Square contributorThe Center Square (The Center Square) – Budget gimmicks, pension debt and late financial reports are leaving Illinois taxpayers in the dark, according...
Democrat Mills to challenge Collins with for U.S. Senate
By Chris WadeThe Center Square Maine's Democratic Gov. Janet Mills is expected to announce a bid for the U.S. Senate with a challenge to Republican Sen. Susan Collins in next...
Some New York school districts spend almost or more than $100,000 a student
By Mark StricherzThe Center Square A half-dozen school districts in New York state reported spending more than $70,000 per student recently, with two districts spending almost or more than $100,000,...
Illinois quick hits: Chicago Jewish Alliance on peace developments; Blue Ribbon Schools announced
By Jim Talamonti | The Center SquareThe Center Square Chicago Jewish Alliance on peace developments The Chicago Jewish Alliance has offered a response to the release of 20 hostages held...
WATCH: Trump’s emergency Guard appeal denied; Fiscal Fallout reviews state salaries
By Greg Bishop | The Center SquareThe Center Square (The Center Square) – In today's edition of Illinois in Focus Daily, The Center Square Editor Greg Bishop gets to the...
Reforms prompt big money appeals in IL biometrics cases
By Jonathan Bilyk | Legal NewslineThe Center Square Even as reforms seem to have edged down the number of biometric privacy lawsuits targeted at businesses in Illinois, appeals courts are...
Trump delivers message of peace, hope during historic Knesset address
By Sarah Roderick-FitchThe Center Square Hope and joy dominated the streets of Israel on Monday as 20 hostages were freed, and President Donald Trump addressed the State of Israel. The...
Meeting Summary and Briefs: Casey City Council for October 6, 2025
The Casey City Council approved a 3-cent per kilowatt-hour increase for the city’s electric utility at its meeting on Monday, October 6, 2025, a move officials said was necessary to...
Casey Amends Nuisance Ordinance to Standardize Penalties
Article Summary: The Casey City Council has approved an ordinance to ensure penalties for nuisance violations are consistent across all sections of the city code. The "clean-up" measure follows a...
Everyday Economics: Data blackout: Why the growth narrative doesn’t hold up
By Orphe DivounguyThe Center Square The federal shutdown has darkened the dashboard. Key September releases are delayed – most notably CPI now slated for Oct. 24, just days before the...
Appeals Court rejects Trump administration bid to lift TRO in Illinois’
By Jim Talamonti | The Center SquareThe Center Square (The Center Square) – The Seventh Circuit U.S. Court of Appeals has denied the portion of the Trump administration’s emergency motion...
Those doxxing, threatening ICE agents, arrested, indicted
By Bethany BlankleyThe Center Square Individuals rioting, doxxing and threatening U.S. Immigration and Customs Enforcement officers and their families continue to be arrested and indicted. Legal action is being taken...
‘The Art of the Heal’: How TrumpRx, most-favored nation pricing, Big Pharma intersect
By Morgan SweeneyThe Center Square AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” pricing and deeply discounted rates on TrumpRx.gov But...
